Skip to main content
. 2020 Feb 24;12(2):520. doi: 10.3390/cancers12020520
TMZ temozolomide
GB glioblastoma
recGB recurrent glioblastoma
ndGB newly diagnosed glioblastoma
GEO Gene Expression Omnibus
GSCs glioma stem cells
ATDs anticancer target drugs
BES balanced efficiency score